glp-1 agonists with cardiovascular benefit The Physiology of Glucagon-like Peptide-1 Receptor Agonists: From Macro-Level Outcomes to Micro-Level Mechanisms The conversation around GLP-1 medications

GLP-1 drugs like Ozempic, Wegovy, and Mounjaro have proven to be very effective in treating diabetes and helping people lose weight, but researchers at the University of Colorado Anschutz Cancer Center are doing studies to see if the medications have another function improving the immune system

Berlin-Chemie and Roche (speakers bureau)

At last there is a promising treatment for this chronic disease FDA-approved GLP-1 Anti-Obesity Medication (AOM) such as Wegovy and Saxenda but the cost implications are concerning

Why is this question important Taking a step back, conceptually, we expect persons who lose weight, irrespective of the mechanism, to lose both fat mass (FM) and fat free mass (FFM) (persons with obesity generally have higher baseline levels of FFM and SMM than do persons without obesity )

A rapid clinical practice update issued by the American Gastroenterology Association advocated an individualised approach, taking into account the indication and urgency of the endoscopic procedure, the indication for GLP-1RA (diabetes or weight loss) and the presence of symptoms.35 The option to omit the dose immediately prior to the endoscopy is applicable for some

You should not change your dosing regimen or stop taking Saxenda (liraglutide) as prescribed without discussing with your provider first